Purdue Pharma Pleads Guilty To FDCA, Kickback Violations, Faces $2B Forfeiture

Mealey's (December 2, 2020, 8:25 AM EST) -- NEWARK, N.J. — OxyContin maker Purdue Pharma L.P. on Nov. 24 was charged and pleaded guilty in a New Jersey federal court to conspiring to violate the Food, Drug and Cosmetic Act (FDCA) and conspiring to violate the Anti-Kickback Statute (United States v. Purdue Pharma L.P., No. 20-cr-1028, D. N.J.)....